Birdshot-like Chorioretinopathy Associated With Pembrolizumab Treatment

JAMA Ophthalmol. 2018 Oct 1;136(10):1205-1207. doi: 10.1001/jamaophthalmol.2018.1851.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Birdshot Chorioretinopathy
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / secondary
  • Chorioretinitis / chemically induced*
  • Chorioretinitis / diagnosis
  • Coloring Agents / administration & dosage
  • Female
  • Fluorescein Angiography
  • Humans
  • Indocyanine Green / administration & dosage
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Melanoma / drug therapy
  • Melanoma / secondary
  • Middle Aged
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology
  • Tomography, Optical Coherence

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Coloring Agents
  • pembrolizumab
  • Indocyanine Green